BRIANNE SHERGILL
@Exome Asset Management Llc
Latest period2024 - Q3ReportedManaged Assets$293.574MTotal holdings59
Assets growth rate161.38%Assets growth rate (2-Q avg)78.78%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Exome Asset Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 59 positions.
Assets under management
The assets under management (AUM) of Exome Asset Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 293.574M in assets, with a quarterly growth rate of 161.38% and a 2-quarter average growth rate of 78.78%. The portfolio is managed by BRIANNE SHERGILL, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SYRSSyros Pharmaceuticals Inc
| 0.44% | $1.284M 597,150 shares@ $2.15 avg price | Increased 275.16% |
ADAGAdagene Inc
| 0.4% | $1.166M 525,250 shares@ $2.23 avg price | Increased 248.14% |
ALVOAlvotech
| 0.37% | $1.072M 90,100 shares@ $11.9 avg price | Decreased -8.98% |
ESTAEstablishment Labs Hldgs Inc
| 0.32% | $938,959 21,700 shares@ $43.27 avg price | |
GOSSGossamer Bio Inc
| 0.32% | $924,254 936,998 shares@ $0.99 avg price | Decreased -16.91% |
APREAprea Therapeutics Inc
| 0.26% | $754,458 274,348 shares@ $2.76 avg price | Increased 100% |
LPTXLeap Therapeutics Inc
| 0.18% | $527,524 205,262 shares@ $2.58 avg price | New Position |
PROCProcaps Group Sa
| 0.1% | $280,451 126,901 shares@ $2.21 avg price | |
PACBPacific Biosciences Calif In
| 0.09% | $256,020 150,600 shares@ $1.7 avg price | Increased 100% |